Recently, China announced its first industrial competitiveness investigation on medical CT ball tube imports. As the trade war between the U.S. and China intensifies, the deployment of this new tool signals a deeper effort to evaluate vulnerabilities within China's key industries.

As bilateral trade tensions continue to rise, China's State Council published a White Paper highlighting the "mutual benefits" in bilateral relations and the harm of U.S. unilateral tariffs. It also attacked the U.S. implementation record of the Phase One Agreement, a deal signed between

In the latest round of the trade war, China has retaliated against the U.S. 84% tariff rate with its own 84% tariff, and has made a few new sanctions announcements as well.

In response to the Trump administration's latest wave of tariffs, Beijing is mobilizing a comprehensive response that spans government statements, diplomatic outreach to American businesses, and a focus on domestic resilience.

In retaliation for the U.S. “reciprocal” tariffs, China has continued its multi-pronged approach to dealing with U.S. unilateral trade measures, encompassing a WTO challenge, retaliatory tariffs, expanded sanction lists, export controls, antitrust review, and other measures. Unlike past instances, however, this time China announced “reciprocal” retaliatory tariffs, with

China's Ministry of Commerce released its services trade data for January and February. Growth in travel and knowledge-based services drove overall expansion, with a narrowing trade deficit.

In March 2025, China's General Administration of Customs (GACC) implemented a series of import suspensions and adjustments. Beyond the high-profile trade dispute with the United States, GACC actions also impacted nations across Africa, Europe, and Asia.